[1]
B. Job, M. Govender, and T. N. Gengiah, “High-dose pyridoxine and peripheral neuropathy: Considerations for clinicians, pharmacists and policy-makers”, S Afr Med J, vol. 116, no. 5, p. e4610, Jun. 2026, doi: 10.7196/SAMJ.2026.v116i5.4610.